Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yanju Bao

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
BMC Musculoskeletal Disorders|May 31, 2022
Knockdown of PAR2 alleviates cancer-induced bone pain by inhibiting the activation of astrocytes and the ERK pathwayYiting Tang, Yupeng Chen, Mingzhu Yang, et al.
Journal of Orthopaedic Surgery (Hong Kong)|August 7, 2024
Naringenin alleviates bone cancer pain via NF-κB/uPA/PAR2 pathway in miceYaoyuan Li, Guangda Zheng, Yiting Tang, et al.
Channels (Austin, Tex.)|February 10, 2015
New insights into protease-activated receptor 4 signaling pathways in the pathogenesis of inflammation and neuropathic pain: a literature reviewYanju Bao, Yebo Gao, Liping Yang, et al.
Channels (Austin, Tex.)|July 16, 2015
The mechanism of μ-opioid receptor (MOR)-TRPV1 crosstalk in TRPV1 activation involves morphine anti-nociception, tolerance and dependenceYanju Bao, Yebo Gao, Liping Yang, et al.
Frontiers in Pharmacology|March 25, 2024
Dysregulation of sphingolipid metabolism in painJianfeng Wang, Guangda Zheng, Linfeng Wang, et al.
International Journal of Cancer|February 25, 2015
Engagement of signaling pathways of protease-activated receptor 2 and μ-opioid receptor in bone cancer pain and morphine toleranceYanju Bao, Yebo Gao, Wei Hou, et al.
Frontiers in Immunology|December 27, 2024
The potential of cellular homing behavior in tumor immunotherapy: from basic discoveries to clinical applications of immune, mesenchymal stem, and cancer cell homingDongtao Li, Yixuan Yang, Guangda Zheng, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|May 13, 2014
Complementary and alternative medicine for cancer pain: an overview of systematic reviewsYanju Bao, Xiangying Kong, Liping Yang, et al.
Regional Anesthesia and Pain Medicine|February 5, 2015
Protease-activated receptor 2 antagonist potentiates analgesic effects of systemic morphine in a rat model of bone cancer painYanju Bao, Wei Hou, Liping Yang, et al.
Oncology Reports|July 3, 2015
Topical treatment with Xiaozheng Zhitong Paste alleviates bone cancer pain by inhibiting proteinase-activated receptor 2 signaling pathwayYanju Bao, Gaimei Wang, Yebo Gao, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
BMC Musculoskeletal Disorders|May 31, 2022
Knockdown of PAR2 alleviates cancer-induced bone pain by inhibiting the activation of astrocytes and the ERK pathwayYiting Tang, Yupeng Chen, Mingzhu Yang, et al.
Journal of Orthopaedic Surgery (Hong Kong)|August 7, 2024
Naringenin alleviates bone cancer pain via NF-κB/uPA/PAR2 pathway in miceYaoyuan Li, Guangda Zheng, Yiting Tang, et al.
Channels (Austin, Tex.)|February 10, 2015
New insights into protease-activated receptor 4 signaling pathways in the pathogenesis of inflammation and neuropathic pain: a literature reviewYanju Bao, Yebo Gao, Liping Yang, et al.
Channels (Austin, Tex.)|July 16, 2015
The mechanism of μ-opioid receptor (MOR)-TRPV1 crosstalk in TRPV1 activation involves morphine anti-nociception, tolerance and dependenceYanju Bao, Yebo Gao, Liping Yang, et al.
Frontiers in Pharmacology|March 25, 2024
Dysregulation of sphingolipid metabolism in painJianfeng Wang, Guangda Zheng, Linfeng Wang, et al.
International Journal of Cancer|February 25, 2015
Engagement of signaling pathways of protease-activated receptor 2 and μ-opioid receptor in bone cancer pain and morphine toleranceYanju Bao, Yebo Gao, Wei Hou, et al.
Frontiers in Immunology|December 27, 2024
The potential of cellular homing behavior in tumor immunotherapy: from basic discoveries to clinical applications of immune, mesenchymal stem, and cancer cell homingDongtao Li, Yixuan Yang, Guangda Zheng, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|May 13, 2014
Complementary and alternative medicine for cancer pain: an overview of systematic reviewsYanju Bao, Xiangying Kong, Liping Yang, et al.
Regional Anesthesia and Pain Medicine|February 5, 2015
Protease-activated receptor 2 antagonist potentiates analgesic effects of systemic morphine in a rat model of bone cancer painYanju Bao, Wei Hou, Liping Yang, et al.
Oncology Reports|July 3, 2015
Topical treatment with Xiaozheng Zhitong Paste alleviates bone cancer pain by inhibiting proteinase-activated receptor 2 signaling pathwayYanju Bao, Gaimei Wang, Yebo Gao, et al.
Pageof 4